Medical News

RSS

ASHP communicates support for Berwick nomination to Senate

The American Society of Health-System Pharmacists (ASHP) communicated its strong support for the nomination of Donald M. Berwick, M.D., as administrator of the Centers for Medicare & Medicaid Services (CMS).

19 Jun 2010

Advocacy groups oppose lawsuits that could undermine new legislation's protections against insurances abuses

The National Organization for Rare Disorders and other leading disease and disabilities advocacy groups have filed an amicus brief urging the courts to protect Americans from lawsuits that would undermine protections provided by the nation's new health care reform legislation.

19 Jun 2010

Ingen Technologies to exhibit, sponsor at upcoming Medtrade conference

Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line for the $8B respiratory market, announced today that the company has officially accepted to be an exhibitor and sponsor at the upcoming Medtrade conference in Atlanta, Georgia from November 15-18, 2010 at the Georgia World Congress Center.

19 Jun 2010

USC researchers study relationship between teenagers' goals and antisocial behaviour

Two researchers from the University of Santiago de Compostela have studied the relationship between teenagers' goals and antisocial behaviour. The results show that the principal goal of young people is to finish their studies and leave home. The most antisocial among them place greater importance on popularity with others.

19 Jun 2010

DEA, Harvard Drug Group announce agreement to modify suspension

Today, the Drug Enforcement Administration and U.S. Attorney's Office, and Harvard Drug Group announced their agreement to immediately modify the suspension, upon certain conditions, of Harvard's registration to distribute schedule III through V controlled substances out of its Livonia Distribution Center, and a mutual commitment to commence discussions, towards resolution of the issues raised in the DEA's suspension order. The suspension remains as to schedule II controlled substances.

19 Jun 2010

HHS Secretary announces new $250M investment to improve health and well-being of Americans

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced $250 million in new Affordable Care Act investments to support prevention activities and develop the nation's public health infrastructure.

19 Jun 2010

Artificial pancreas system reduces risk of nocturnal hypoglycemia

An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.

19 Jun 2010

Date set for Ryan Phua Memorial Kids' Ride, Burlingame Criterium

The 7th annual Ryan Phua Memorial Kids' Ride, featuring more than 700 kids of all ages, will once again provide one of the key highlights at the 24th annual Burlingame Criterium, set for Sunday, June 27, 2010. The race activities will fill the streets, restaurants and shops of downtown Burlingame with thousands of competitive cyclists, children, volunteers and spectators. Adding to the excitement of Ryan's Ride, the day's multiple races will culminate in a Men's pro event and a separate Women's pro event.

19 Jun 2010

Report examines G8's $22B food security pledge, highlights need for funding delivery

A report from the anti-poverty group ActionAid finds that less than one-third of the $22 billion that was pledged to improve food security during a 2009 G8 meeting in L'Aquila, Italy, is from new funding sources, the U.K. Press Association reports (6/18).

19 Jun 2010

Medicare begins 21% payment cuts to physicians

Today, Medicare begins processing physician payments with the drastic 21 percent cut that Congress failed to stop, and now seniors and physicians are paying the price of Congress' Medicare mismanagement.

19 Jun 2010

Oncolytics Biotech issued patent that covers methods for treating cell proliferative disorders

Oncolytics Biotech Inc. today announced that it has been granted its 35th U.S. Patent, # 7,731,951 entitled "Viruses for the Treatment of Cellular Proliferative Disorders." The patent claims cover methods for treating cell proliferative disorders by administering modified vaccinia virus to proliferating cells having an activated Ras-pathway.

19 Jun 2010

TFAH recognizes steps taken by Obama Administration on Prevention and Public Health Fund

Trust for America's Health today recognized the crucial first steps taken by the Obama Administration to allocate the recent health reform Act's Prevention and Public Health Fund, but acknowledged that in year one, half of the Fund's dollars were redirected outside the scope of its Congressional intent.

19 Jun 2010

BioTime announces warrant discount offer

BioTime, Inc. announced today that it is commencing a warrant discount offer under which it will permit holders of its common share purchase warrants expiring October 31, 2010 to exercise their warrants at a discounted price of $1.818 per share, which represents a discount of $0.182 from the regular warrant exercise price of $2.00 per share.

19 Jun 2010

AdnaGen signs option agreement to license specific antibodies to KellBenx

AdnaGen AG, a subsidiary of OncoVista Innovative Therapies, Inc., a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable safe, targeted personal cancer treatments, today announced that it has entered into an option agreement to license specific antibodies to KellBenx Inc., a New York-based private biotech firm.

19 Jun 2010

Conscious sedation for glioma resection shortens hospital stay

The recovery time and cost of brain-tumor surgery might both be reduced if surgery is performed while patients are awake during part of the procedure, according to a new study conducted at The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

19 Jun 2010

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

NexBio, Inc. announced today the publication of a "Major Article" in the Journal of Infectious Diseases of a preclinical study showing that treatment with DAS181 (Fludase) inhibits infection with multiple human parainfluenza virus strains. DAS181 is a broad spectrum host-targeted investigational drug candidate for treatment and prevention of Influenza-Like Illness.

19 Jun 2010

Health Robotics announces new Canadian marketing contracts for i.v.STATION, i.v.SOFT

Health Robotics announced that its joint-venture Health Robotics Canada Inc. (HRCI), a leading Canadian Pharmaceutical Company, and a well-established Quebec-based Medical Device Technology company have all recently signed marketing agreements in order to expand into Canada the market presence of i.v.STATION and i.v.SOFT, revolutionary technologies that provide automated sterile compounding of intravenous medications and parenteral nutrition to hospitals.

19 Jun 2010

ARS research physiologist develops preliminary model that predicts individual's vitamin D requirements

Your skin tone and the amount of sunshine you receive--in addition to what foods you eat--all can influence the amount of vitamin D that your body has on hand for optimum health. In a preliminary and apparently first-of-its-kind study, Agricultural Research Service research physiologist Charles B. Stephensen and colleagues have developed a preliminary model that predicts an individual's vitamin D requirements.

19 Jun 2010

Bracco release confirms Positron's market growth prediction of cardiac PET

Positron Corporation, a leader as a molecular imaging and solutions company specializing in the field of Nuclear Cardiology, cites an article posted on AuntMinnie.com, the largest community website for medical imaging professionals, relating to the growth in cardiac PET.

19 Jun 2010

ThermoGenesis to seek stockholder approval for reverse stock split

ThermoGenesis Corp., a leading supplier of innovative products and services that process and store adult stem cells, said today it will seek stockholder approval of an authorization enabling its Board of Directors in its discretion to affect a reverse stock split in the range of one-for-three to one-for-five shares of common stock in the near future, if required to maintain NASDAQ listing. The authorization will be voted upon during a special meeting of stockholders to be held on Monday, August 9th.

19 Jun 2010

Medical News

ASHP communicates support for Berwick nomination to Senate

Advocacy groups oppose lawsuits that could undermine new legislation's protections against insurances abuses

Ingen Technologies to exhibit, sponsor at upcoming Medtrade conference

USC researchers study relationship between teenagers' goals and antisocial behaviour

DEA, Harvard Drug Group announce agreement to modify suspension

HHS Secretary announces new $250M investment to improve health and well-being of Americans

Artificial pancreas system reduces risk of nocturnal hypoglycemia

Date set for Ryan Phua Memorial Kids' Ride, Burlingame Criterium

Report examines G8's $22B food security pledge, highlights need for funding delivery

Medicare begins 21% payment cuts to physicians

Oncolytics Biotech issued patent that covers methods for treating cell proliferative disorders

TFAH recognizes steps taken by Obama Administration on Prevention and Public Health Fund

BioTime announces warrant discount offer

AdnaGen signs option agreement to license specific antibodies to KellBenx

Conscious sedation for glioma resection shortens hospital stay

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

Health Robotics announces new Canadian marketing contracts for i.v.STATION, i.v.SOFT

ARS research physiologist develops preliminary model that predicts individual's vitamin D requirements

Bracco release confirms Positron's market growth prediction of cardiac PET

ThermoGenesis to seek stockholder approval for reverse stock split

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News